共 50 条
- [42] Osimertinib in EGFR T790M-Positive Lung Cancer NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (20): : 1992 - 1993
- [46] Squamous cell transformation as a mechanism of acquired resistance to tyrosine kinase inhibitor in EGFR-mutated lung adenocarcinoma: a report of two cases RESPIROLOGY CASE REPORTS, 2020, 8 (02):
- [48] Rare Mechanism of Acquired Resistance to Osimertinib in Korean Patients with EGFR-Mutated Non-small Cell Lung Cancer CANCER RESEARCH AND TREATMENT, 2019, 51 (01): : 408 - 412